T-cell prolymphocytic leukemia surgery: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 2: Line 2:
{{T-cell prolymphocytic leukemia}}                                                                 
{{T-cell prolymphocytic leukemia}}                                                                 
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}}
{{CMG}}; {{AE}}{{Qurrat}}, {{MV}}
==Overview==


==Surgery==
==Surgery==

Revision as of 20:17, 28 March 2019

T-cell prolymphocytic leukemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating T-cell prolymphocytic leukemia historical perspective from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

T-cell prolymphocytic leukemia surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of T-cell prolymphocytic leukemia surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on T-cell prolymphocytic leukemia surgery

CDC on T-cell prolymphocytic leukemia surgery

T-cell prolymphocytic leukemia surgery in the news

Blogs on T-cell prolymphocytic leukemia surgery

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for T-cell prolymphocytic leukemia surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2], Maria Fernanda Villarreal, M.D. [3]

Surgery

  • Autologous and allogeneic stem cell transplants is the mainstay of therapy for patients who achieve remission.

References

Template:WH Template:WS